Literature DB >> 20478262

Tau protein degradation is catalyzed by the ATP/ubiquitin-independent 20S proteasome under normal cell conditions.

Tilman Grune1, Diana Botzen, Martina Engels, Peter Voss, Barbara Kaiser, Tobias Jung, Stefanie Grimm, Gennady Ermak, Kelvin J A Davies.   

Abstract

Tau is the major protein exhibiting intracellular accumulation in Alzheimer disease. The mechanisms leading to its accumulation are not fully understood. It has been proposed that the proteasome is responsible for degrading tau but, since proteasomal inhibitors block both the ubiquitin-dependent 26S proteasome and the ubiqutin-independent 20S proteasome pathways, it is not clear which of these pathways is involved in tau degradation. Some involvement of the ubiquitin ligase, CHIP in tau degradation has also been postulated during stress. In the current studies, we utilized HT22 cells and tau-transfected E36 cells in order to test the relative importance or possible requirement of the ubiquitin-dependent 26S proteasomal system versus the ubiquitin-independent 20S proteasome, in tau degradation. By means of ATP-depletion, ubiquitinylation-deficient E36ts20 cells, a 19S proteasomal regulator subunit MSS1-siRNA approaches, and in vitro ubiquitinylation studies, we were able to demonstrate that ubiquitinylation is not required for normal tau degradation. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20478262      PMCID: PMC2904402          DOI: 10.1016/j.abb.2010.05.008

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  55 in total

Review 1.  Regulation of cellular polyamines by antizyme.

Authors:  P Coffino
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

Review 2.  Oxidative stress, aging and the proteasomal system.

Authors:  T Grune
Journal:  Biogerontology       Date:  2000       Impact factor: 4.277

3.  CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein.

Authors:  S Murata; Y Minami; M Minami; T Chiba; K Tanaka
Journal:  EMBO Rep       Date:  2001-11-21       Impact factor: 8.807

4.  Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome.

Authors:  Reshma Shringarpure; Tilman Grune; Jana Mehlhase; Kelvin J A Davies
Journal:  J Biol Chem       Date:  2002-10-24       Impact factor: 5.157

5.  Proteasomal degradation of tau protein.

Authors:  Della C David; Robert Layfield; Louise Serpell; Yolanda Narain; Michel Goedert; Maria Grazia Spillantini
Journal:  J Neurochem       Date:  2002-10       Impact factor: 5.372

6.  MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein.

Authors:  Patima Sdek; Haoqiang Ying; Donny L F Chang; Wei Qiu; Hongwu Zheng; Robert Touitou; Martin J Allday; Zhi-Xiong Jim Xiao
Journal:  Mol Cell       Date:  2005-12-09       Impact factor: 17.970

7.  Ca2+-free calmodulin and calmodulin damaged by in vitro aging are selectively degraded by 26 S proteasomes without ubiquitination.

Authors:  E Tarcsa; G Szymanska; S Lecker; C M O'Connor; A L Goldberg
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

8.  Hydrogen peroxide-induced structural alterations of RNAse A.

Authors:  P Lasch; T Petras; O Ullrich; J Backmann; D Naumann; T Grune
Journal:  J Biol Chem       Date:  2000-12-13       Impact factor: 5.157

9.  Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.

Authors:  Susi Keck; Robert Nitsch; Tilman Grune; Oliver Ullrich
Journal:  J Neurochem       Date:  2003-04       Impact factor: 5.372

Review 10.  The ubiquitin-proteasome system in Alzheimer's disease.

Authors:  Salvatore Oddo
Journal:  J Cell Mol Med       Date:  2008-02-08       Impact factor: 5.310

View more
  30 in total

Review 1.  The Proteasome and Oxidative Stress in Alzheimer's Disease.

Authors:  Vicent Bonet-Costa; Laura Corrales-Diaz Pomatto; Kelvin J A Davies
Journal:  Antioxid Redox Signal       Date:  2016-08-25       Impact factor: 8.401

2.  Accelerated neurodegeneration through chaperone-mediated oligomerization of tau.

Authors:  Laura J Blair; Bryce A Nordhues; Shannon E Hill; K Matthew Scaglione; John C O'Leary; Sarah N Fontaine; Leonid Breydo; Bo Zhang; Pengfei Li; Li Wang; Carl Cotman; Henry L Paulson; Martin Muschol; Vladimir N Uversky; Torsten Klengel; Elisabeth B Binder; Rakez Kayed; Todd E Golde; Nicole Berchtold; Chad A Dickey
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 3.  Regulation of proteasome activity in health and disease.

Authors:  Marion Schmidt; Daniel Finley
Journal:  Biochim Biophys Acta       Date:  2013-08-27

4.  Small Molecule Enhancement of 20S Proteasome Activity Targets Intrinsically Disordered Proteins.

Authors:  Corey L Jones; Evert Njomen; Benita Sjögren; Thomas S Dexheimer; Jetze J Tepe
Journal:  ACS Chem Biol       Date:  2017-08-01       Impact factor: 5.100

Review 5.  mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia.

Authors:  Fabio Di Domenico; Antonella Tramutola; Cesira Foppoli; Elizabeth Head; Marzia Perluigi; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2017-08-12       Impact factor: 7.376

6.  SRCP1 Conveys Resistance to Polyglutamine Aggregation.

Authors:  Stephanie Santarriaga; Holly N Haver; Adam J Kanack; Alicia S Fikejs; Samantha L Sison; John M Egner; Jonathan R Bostrom; Emily R Seminary; R Blake Hill; Brian A Link; Allison D Ebert; K Matthew Scaglione
Journal:  Mol Cell       Date:  2018-07-19       Impact factor: 17.970

Review 7.  It's all about tau.

Authors:  Cheril Tapia-Rojas; Fabian Cabezas-Opazo; Carol A Deaton; Erick H Vergara; Gail V W Johnson; Rodrigo A Quintanilla
Journal:  Prog Neurobiol       Date:  2018-12-31       Impact factor: 11.685

8.  Synthesis of Lithocholic Acid Derivatives as Proteasome Regulators.

Authors:  Zhao Dang; Kathy Jung; Keduo Qian; Kuo-Hsiung Lee; Li Huang; Chin-Ho Chen
Journal:  ACS Med Chem Lett       Date:  2012-08-15       Impact factor: 4.345

Review 9.  Protein Oxidation in Aging: Does It Play a Role in Aging Progression?

Authors:  Sandra Reeg; Tilman Grune
Journal:  Antioxid Redox Signal       Date:  2014-10-09       Impact factor: 8.401

Review 10.  The Immunoproteasome in oxidative stress, aging, and disease.

Authors:  Helen K Johnston-Carey; Laura C D Pomatto; Kelvin J A Davies
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-04-20       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.